Sign Up to like & get
recommendations!
0
Published in 2019 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2018.4717
Abstract: Importance Hospitalizations for durable left ventricular assist device (LVAD) implants are expensive and increasingly common. Insights into center-level variation in Medicare spending for these hospitalizations are needed to inform value improvement efforts. Objective To examine…
read more here.
Keywords:
durable lvad;
variation medicare;
spending;
medicare spending ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-017-4498-8
Abstract: PurposeDespite benefits for patients, sustainability of breast cancer navigation programs is challenging due to the lack of reimbursement for navigators. This analysis describes distress reported by breast cancer patients to navigators and the impact of…
read more here.
Keywords:
medicare spending;
breast cancer;
navigation;
cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of the American Geriatrics Society"
DOI: 10.1111/jgs.17835
Abstract: Over 6 million Americans have Alzheimer's Disease or Related Dementia (ADRD) but whether spikes in spending surrounding a new diagnosis reflect pre‐diagnosis morbidity, diagnostic testing, or treatments for comorbidities is unknown.
read more here.
Keywords:
dementia diagnosis;
diagnosis;
diagnosis among;
medicare spending ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2021 at "Health affairs"
DOI: 10.1377/hlthaff.2020.01006
Abstract: In recent years direct ownership of physician practices by hospitals and health systems (that is, vertical integration) has become a prominent feature of the US health care system. One unexplored impact of vertical integration is…
read more here.
Keywords:
medicare spending;
integration;
per 000;
care ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/m21-4442
Abstract: BACKGROUND The U.S. Food and Drug Administration provides accelerated approval to drugs on the basis of surrogate end points deemed to be "reasonably likely" to predict clinical benefit. To receive full approval, drugs must complete…
read more here.
Keywords:
full approval;
approval;
spending drugs;
medicare spending ... See more keywords